Literature DB >> 23000868

Serological trail of Brucella infection in an urban slum population in Brazil.

Martha Olivera Angel1, Paula Ristow, Albert Icksang Ko, Cecilia Di-Lorenzo.   

Abstract

INTRODUCTION: Brucellosis is a re-emerging zoonosis with new cases reported each year in many Latin American countries, but it is mostly under-recognized. This study presents a serological investigation of infection with Brucella abortus and Brucella canis in a poor urban community in the city of Salvador, Brazil.
METHODOLOGY: Human sera (n = 180) were randomly selected from 3,171 samples taken from healthy individuals during 2003-2004 and tested with C-ELISA for B. abortus and I-ELISA for B. canis.
RESULTS: Thirteen percent (24/180) of the individuals were positive for B. abortus and 4.6 % (8/174) were positive for B. canis. Among the variables studied only age (older than 45 years) appeared to be a risk factor for the detection of Brucella antibodies.
CONCLUSION: These results indicate the presence of Brucella infection in this settlement and highlight the need to understand the epidemiology of infection under these circumstances to establish the necessary measures for surveillance and control.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000868      PMCID: PMC3800144          DOI: 10.3855/jidc.2347

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  18 in total

1.  Serologic survey for agglutinins to Brucella canis in Florida residents.

Authors:  G L Hoff; N J Schneider
Journal:  Am J Trop Med Hyg       Date:  1975-01       Impact factor: 2.345

2.  Correlation between animal and human brucellosis in Italy during the period 1997-2002.

Authors:  F De Massis; A Di Girolamo; A Petrini; E Pizzigallo; A Giovannini
Journal:  Clin Microbiol Infect       Date:  2005-08       Impact factor: 8.067

3.  The incidence of Brucella canis antibodies in sera of military recruits.

Authors:  G E Lewis; J K Anderson
Journal:  Am J Public Health       Date:  1973-03       Impact factor: 9.308

4.  Seroepidemiological investigation of Brucella canis antibodies in different human population groups.

Authors:  P W Monroe; S L Silberg; P M Morgan; M Adess
Journal:  J Clin Microbiol       Date:  1975-11       Impact factor: 5.948

5.  Competitive enzyme immunoassay for diagnosis of human brucellosis.

Authors:  N E Lucero; L Foglia; S M Ayala; D Gall; K Nielsen
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

6.  Molecular characterization of Brucella strains isolated from marine mammals.

Authors:  B J Bricker; D R Ewalt; A P MacMillan; G Foster; S Brew
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

7.  Brucellosis in household members of Brucella patients residing in a large urban setting in Peru.

Authors:  Marjorie Mendoza-Núñez; Maximilian Mulder; María Pía Franco; Kathlène S J S M Maas; Maria L Castañeda; Nilo Bonifacio; Jesús Chacaltana; Elena Yagui; Robert H Gilman; Benjamin Espinosa; David Blazes; Eric Hall; Theresia H Abdoel; Henk L Smits
Journal:  Am J Trop Med Hyg       Date:  2008-04       Impact factor: 2.345

8.  How human brucellosis incidence in urban Kampala can be reduced most efficiently? A stochastic risk assessment of informally-marketed milk.

Authors:  Kohei Makita; Eric M Fèvre; Charles Waiswa; Mark C Eisler; Susan C Welburn
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

Review 9.  Review of clinical and laboratory features of human brucellosis.

Authors:  B G Mantur; S K Amarnath; R S Shinde
Journal:  Indian J Med Microbiol       Date:  2007-07       Impact factor: 0.985

Review 10.  Human brucellosis.

Authors:  María Pía Franco; Maximilian Mulder; Robert H Gilman; Henk L Smits
Journal:  Lancet Infect Dis       Date:  2007-12       Impact factor: 25.071

View more
  7 in total

1.  Detection of Brucella spp. in dogs at Pantanal wetlands.

Authors:  Ana Laura Bello de Oliveira; Gabriel Carvalho de Macedo; Gracia Maria Soares Rosinha; Jhessyca Leal Melgarejo; Andreza Gabriela Leão Alves; Wanessa Teixeira Gomes Barreto; Filipe Martins Santos; João Bosco Vilela Campos; Heitor Miraglia Herrera; Carina Elisei de Oliveira
Journal:  Braz J Microbiol       Date:  2018-12-10       Impact factor: 2.476

2.  Epidemiological characterization of notified human brucellosis cases in Southern Brazil.

Authors:  Fabricio Bernardi; Marina Gabriela Possa; Camila Elizandra Rossi; Luíz Guilherme Dercore Benevenuto; Iucif Abrão Nascif Junior; Jacqueline de Jesus; Barbara Cardoso de Oliveira; Carla Zanelatto; Joice Gama Sena; Carlos Eduardo Fonseca-Alves; Fabiana Elias
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-06-06       Impact factor: 2.169

3.  Brucella Laboratory Exposures in Brazil: Rare or Unnoticed?

Authors:  Felipe Francisco Tuon; Juliana Clelia Cequinel; Keite da Silva Nogueira; Guilherme Nardi Becker
Journal:  Am J Trop Med Hyg       Date:  2020-09-03       Impact factor: 3.707

Review 4.  The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis.

Authors:  Aseem Pandey; Ana Cabello; Lavoisier Akoolo; Allison Rice-Ficht; Angela Arenas-Gamboa; David McMurray; Thomas A Ficht; Paul de Figueiredo
Journal:  PLoS Negl Trop Dis       Date:  2016-08-18

5.  Variability in the response of canine and human dendritic cells stimulated with Brucella canis.

Authors:  Myriam Pujol; Francisca Castillo; Carla Alvarez; Camila Rojas; Consuelo Borie; Arturo Ferreira; Rolando Vernal
Journal:  Vet Res       Date:  2017-11-02       Impact factor: 3.683

6.  Outbreak of human brucellosis in Southern Brazil and historical review of data from 2009 to 2018.

Authors:  Tamilly Silva Lemos; Juliana Clelia Cequinel; Tania Portela Costa; Amanda Boni Navarro; Andressa Sprada; Flávia Kazumi Shibata; Regina Gondolfo; Felipe Francisco Tuon
Journal:  PLoS Negl Trop Dis       Date:  2018-09-18

7.  Brucellosis in Dogs and Public Health Risk.

Authors:  Martha E Hensel; Maria Negron; Angela M Arenas-Gamboa
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.